The biopharmaceutical industry contemplates product innovation within the changing landscape of healthcare.
Michael N. Abrams
Advertisement
Articles by Michael N. Abrams
A look back at the history of orphan drugs in the industry.
Rather than seeking a single indication for one large group, the orphan-drug approach segments the market for a drug more minutely.
Advertisement
Latest Updated Articles
The Affordable Care Act's Impact on Innovation in BiopharmaFebruary 1st 2014
- The Growing Orphan-Drug Paradigm
April 1st 2012
A 25-Year Retrospective on Orphan DrugsAugust 1st 2012
Advertisement
Advertisement
Trending on BioPharm International
1
Sanofi Begins Construction of EU-Backed Insulin Plant in Frankfurt
2
TaiMed’s Anti-CD4 Antibody TMB-365 Reduces HIV Viral Load in Phase 1, Supporting Long-Acting Combination Regimens
3
Akeso's Ivonescimab Enters Phase 2/3 Biliary Tract Cancer Trial in US
4
Nano24's Inhaled EXO-CD24 Cuts ARDS Mortality in Phase 2b Trial
5